Account
Dentsu Webchutney wins digital mandate for Tanishq
NEW DELHI: Dentsu Webchutney India has bagged the digital mandate for Titan’s jewellery brand, Tanishq. The account was won following a multi-agency pitch.
Championing today’s bride’s love for tradition without being bound by the constraints of it, was the challenge that inspired Dentsu Webchutney to take on this latest mandate. The agency aims to chart an aggressive creative growth strategy which captures the timeless essence of Tanishq, the agency said in a press statement.
Dentsu Webchutney planning director Shambhavi Ramanathan said, “We are thrilled to be associating with one of the finest brands in India – Tanishq. As champions of change, always testing waters and staying ahead of its time, we found a complete vision match as digital brand-building partners. It is a privilege to join forces to shape emerging culture and progressive womanhood.”
Dentsu Webchutney creative director Binaifer Dulani added, “With a fierce, woman-strong team and some of the brightest young talent from the industry, we look forward to making jewellery a powerful form of self-expression through digital.”
Ranjani Krishnaswamy, general manager-marketing, Tanishq, added, “We’re absolutely thrilled to join forces with the young and dynamic team at Dentsu Webchutney to lead our digital mandate. Partnering with them sets us off on yet another exciting journey of meaningfully engaging with our consumers on digital. We’re sure that Dentsu Webchutney, with their nuanced understanding of the digital landscape, will fuel our vision to be the country’s most loved jewellery brand.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
